InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Tarsus Pharmaceuticals, Inc.

TARS Clue Score56
United States Fiscal year ends December CIK 0001819790
$73.16 +1.30% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $73.16 +202.31% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 16 Oct 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2018Net income−1.3Fiscal year 2019Operating income−4.3Net income−4.7Fiscal year 2020Revenue0.0Operating income−27.0Net income−26.8EPS, diluted−4.32Fiscal year 2021Revenue57.0Operating income−12.2Net income−13.8EPS, diluted−0.67Fiscal year 2022Revenue25.8 −54.7%Operating income−62.7Net income−62.1EPS, diluted−2.52Fiscal year 2023Revenue17.4 −32.4%Operating income−143.2Net income−135.9EPS, diluted−4.62Fiscal year 2024Revenue183.0 +948.6%Operating income−120.6Net income−115.6EPS, diluted−3.07Fiscal year 2025Revenue451.4 +146.7%Operating income−71.0Net income−66.4EPS, diluted−1.59
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a 0.0 57.0 25.8 17.4 183.0 451.4
Growth −54.7% −32.4% +948.6% +146.7%
Operating income n/a −4.3 −27.0 −12.2 −62.7 −143.2 −120.6 −71.0
Net income −1.3 −4.7 −26.8 −13.8 −62.1 −135.9 −115.6 −66.4
Growth
EPS, diluted n/a n/a −4.32 −0.67 −2.52 −4.62 −3.07 −1.59

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2018Fiscal year 2019Fiscal year 2020Fiscal year 2021Operating margin−21.3%Net margin−24.2%Free cash flow margin5.5%Fiscal year 2022Operating margin−242.9%Net margin−240.5%Free cash flow margin−191.9%Fiscal year 2023Operating margin−820.5%Net margin−778.9%Free cash flow margin−682.0%Fiscal year 2024Operating margin−65.9%Net margin−63.2%Free cash flow margin−46.2%Fiscal year 2025Operating margin−15.7%Net margin−14.7%Free cash flow margin−4.9%
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a n/a −21.3% −242.9% −820.5% −65.9% −15.7%
Net margin n/a n/a n/a −24.2% −240.5% −778.9% −63.2% −14.7%
Free cash flow margin n/a n/a n/a 5.5% −191.9% −682.0% −46.2% −4.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Fiscal year 2019Operating cash flow−3.7Capital expenditure−0.2Free cash flow−3.8Fiscal year 2020Operating cash flow−21.1Capital expenditure−0.5Free cash flow−21.6Fiscal year 2021Operating cash flow3.7Capital expenditure−0.6Free cash flow3.2Fiscal year 2022Operating cash flow−49.0Capital expenditure−0.5Free cash flow−49.5 −1,666.6%Fiscal year 2023Operating cash flow−117.5Capital expenditure−1.5Free cash flow−119.0Fiscal year 2024Operating cash flow−83.0Capital expenditure−1.6Free cash flow−84.6Fiscal year 2025Operating cash flow−12.5Capital expenditure−9.9Free cash flow−22.3
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow n/a −3.7 −21.1 3.7 −49.0 −117.5 −83.0 −12.5
Capital expenditure n/a −0.2 −0.5 −0.6 −0.5 −1.5 −1.6 −9.9
Free cash flow n/a −3.8 −21.6 3.2 −49.5 −119.0 −84.6 −22.3
Growth −1,666.6%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2018Cash2.4Shareholders’ equity−1.4Fiscal year 2019Cash58.0Shareholders’ equity−6.0Fiscal year 2020Cash168.1Shareholders’ equity166.0Fiscal year 2021Cash171.3Total debt0.0Net cash (debt)171.3Shareholders’ equity166.7Debt to equity0.00Fiscal year 2022Cash71.7Total debt19.4Net cash (debt)52.2Shareholders’ equity192.9Debt to equity0.10Fiscal year 2023Cash224.9Total debt29.8Net cash (debt)195.1Shareholders’ equity197.0Debt to equity0.15Fiscal year 2024Cash94.8Total debt71.8Net cash (debt)23.0Shareholders’ equity224.5Debt to equity0.32Fiscal year 2025Cash183.6Total debt72.4Net cash (debt)111.2Shareholders’ equity343.4Debt to equity0.21
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 2.4 58.0 168.1 171.3 71.7 224.9 94.8 183.6
Total debt n/a n/a n/a 0.0 19.4 29.8 71.8 72.4
Net cash (debt) n/a n/a n/a 171.3 52.2 195.1 23.0 111.2
Shareholders’ equity −1.4 −6.0 166.0 166.7 192.9 197.0 224.5 343.4
Debt to equity n/a n/a n/a 0.00 0.10 0.15 0.32 0.21

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
n/a n/a n/a −21.3% −242.9% −820.5% −65.9% −15.7%
n/a n/a n/a −24.1% −240.5% −778.9% −63.2% −14.3%
n/a n/a n/a −24.2% −240.5% −778.9% −63.2% −14.7%
n/a n/a n/a 5.5% −191.9% −682.0% −46.2% −4.9%
Spending
n/a n/a n/a 73.1% 165.1% 288.4% 29.2% 14.3%
n/a n/a n/a 44.5% 174.1% 623.0% 129.7% 94.7%
n/a n/a n/a 1.0% 2.0% 8.6% 0.9% 2.2%
Returns
n/a n/a −16.2% −8.3% −32.2% −69.0% −51.5% −19.3%
n/a −8.0% −15.6% −7.7% −27.2% −51.2% −30.7% −11.8%
Balance and payout
n/a n/a n/a 0.00 0.10 0.15 0.32 0.21
n/a 1.6% 3.5% 6.8% 15.3% 25.8% 40.4% 38.9%